Objectives: To investigate the reasons for hospitalization and its outcome in the era of highly active antiretroviral therapy (HAART) in Barbados. This report also describes the profiles of the HIV-infected persons who were hospitalized in the HAART era. Methods: The authors examined the admission case notes to conduct an observational, retrospective study of all HIV-infected patients admitted to the Queen Elizabeth Hospital (QEH) during September 1, 2004, through March 31, 2005. Data collected included patients' profile, including the date of diagnosis of HIV infection. Outcome of the current admission in terms of discharge or death and the final diagnosis at the time of discharge or death was noted. Results: Over the 6-month period, there were 160 adult admissions to the QEH where HIV/AIDS was at least one of the final diagnoses. Eighty-four (52.5%) admissions were in persons who were known to be HIV infected prior to the current admission, where a diagnosis of HIV infection was made for the first time during the current hospitalization in the remaining 76 (47.5%) cases. Nearly two thirds of those hospitalized and who had a CD4 count done had CD4 counts of < < 200. Overall, opportunistic infection was the most common (38.1%), at discharge or as a final diagnosis, followed by serious bacterial infections, anemia, and HIV nephropathy. The outcome of these admissions was death in 30 (18.7%) cases, whereas the patient was discharged in the remaining 130 (81.3%) cases. Conclusions: A significant proportion of the hospitalized HIV-infected persons in the HAART era is newly diagnosed. The majority of those hospitalized had severe immunodeficiency, and consequently opportunistic infection was the most common final diagnosis.
The introduction of highly active antiretroviral therapy (HAART) has led to a decline in overall hospitalization rates as well as a reduction in morbidity from HIV infection [1] [2] [3] ; however, this decline has been unevenly distributed and inconsistent. [4] [5] [6] [7] [8] There are reports that have noted a plateau effect or even an increase in hospitalizations due to a relative increase in hospitalizations for non-HIV-related reasons, such as drug toxicity, chronic liver disease, and non-HIVassociated neoplasm. 4, 5 It is clear that the interactions of morbidity, mortality, and hospitalizations due to HIV remain complex in the HAART era and may vary across various demographic and geographic groups. However, most reports of hospitalization from HIV infection in the HAART era are from the developed countries. There are very few published studies on HIVrelated hospitalizations from the developing countries, and all these reports are from settings where HAART was not used. [9] [10] [11] The impact of the reduction in HIV/ AIDS-related morbidity and hospitalization in the HAART era in the Caribbean populations has not been characterized to date, and there is no published report from the English-speaking Caribbean countries on this subject. Barbados is one of the English-speaking Caribbean countries that has made great progress in tackling this HIV epidemic over the past decade, especially in the prevention of mother-to-child transmission of HIV and in the treatment of HIV-infected persons after the introduction of HAART in early 2000. 12, 13 We investigated hospitalizations among the HIV-infected persons in this country to identify causes of hospitalization among HIV-infected persons in the HAART era.
Methods
The Queen Elizabeth Hospital (QEH) is the only hospital with facility for the in-patient care of HIV-infected persons in the whole of Barbados. From September 1, 2004 , to March 31, 2005 , there were 2369 adult (older than 16 years) medical admissions to this hospital. The hospital maintains a detailed record of all inpatient admissions. Ambulatory care and management of HIV-infected persons in this country are coordinated and provided through a centralized HIV clinic called the Ladymeade Reference Unit (LRU). Care and treatment including HAART has been available for the HIV-infected persons in Barbados since 2002 at no direct cost at the point of delivery. There was a total of 850 HIV-infected adults registered at the LRU from among an estimated 2650 HIVinfected adults living in Barbados. Unique patient identification unit numbers were used to identify the cohort across both services and databases.
We examined all the admissions where the person was known to be HIV infected or was diagnosed to be HIV infected during the course of the hospital stay, to conduct an observational, retrospective study of all HIV-infected patients admitted to the QEH during September 1, 2004 , through March 31, 2005 . Data collected included patient-related information, history of drug abuse, self-described sexual orientation, date of diagnosis of HIV infection, CD4 counts and viral load values at the time of diagnosis and at the time of current admission, and whether they received HAART prior to current admission. For persons who were on HAART at the time of current admission, duration of HAART, nature of HAART regimen, failure of any previous regimen, and adherence to HAART regimen were recorded. Outcome of the current admission in terms of discharge or death and the final diagnosis at the time of discharge or death were noted.
Outcome variables were the frequency and causes of hospitalization among HIV-infected persons, duration of hospital stay, and outcome of hospitalization in terms of death or discharge. The proportion of HIV-related hospitalizations in persons not known to be HIV infected prior to their admission and the proportion of HIV-related admissions occurring in persons attending the LRU for their follow-up care were also measured. These outcome variables were correlated with the age, gender, CD4 counts, and viral load values at the time of diagnosis and at the time of current hospitalization and prior HAART. Bivariate relationships between variables were investigated using the chi-square test of association for nominal variables. A .05 significance level was used for all statistical tests. Data were stored in a specially designed Microsoft Access database and were analyzed using SPSS statistical software package for Windows version 11. Microsoft Office Excel was used for the generation of all graphs and tables.
Results
Between September 1, 2004, and March 31, 2005, over a 6-month period, there were 127 adults who were admitted to the QEH on one or more occasions, accounting for a total of 160 admissions where HIV/AIDS was at least 1 of the final diagnoses. Total adult medical admissions to the QEH over the same period were 2369, and HIV-related admissions accounted for 6.7% of all medical admissions. Table 1 shows the characteristics of the HIV-infected persons hospitalized during the study period. The majority of patients were Afro-Caribbean, and their median age at the time of hospitalization was 41 years (range, 16-71 years). Of the 127 HIV-infected persons who were admitted during the study period, 11.7% were men who had sex with men, 7.8% smoked marijuana and/or cocaine, and none were intravenous drug users. During the 12-month study period, 16 (12.6%) patients had multiple admissions, ranging between 2 and 5 admissions, and accounted for 28.5% of all the admissions.
Of the 160 adult admissions to the QEH with the diagnosis of HIV/AIDS, in 84 (52.5%) admissions, the person was known to be HIV infected prior to the current admission, whereas diagnosis of HIV infection was made for the first time during the current hospitalization in the remaining 76 (47.5%) hospitalizations. Of those hospitalized and who had a CD4 count done at or around the time of admission, 65.5% had a CD4 count of less than 200 and 53.7% of those who had a viral load estimated had a viral load value of more than 100,000 copies/mL ( Table 2) . For those 84 patients known to be HIV infected at the time of their current hospitalization, median duration of time since their diagnosis was 22 months and a little more than half were on HAART for a median duration of 9 months. In half of those on HAART, adherence was categorized as being poor (taking less than 90% of the prescribed medications). Both absence of prior diagnosis of HIV infection (newly diagnosed HIV infection) and absence of prior HAART were associated with significantly higher risk of having a CD4 count < 200 at the time of hospitalization ( Figure 1 ). Overall, opportunistic infection was one of the discharge diagnoses in 38.1%, followed by serious bacterial infections, anemia, and HIV nephropathy, in order of frequency (Table 3 ). In 48 cases, opportunistic infection was the primary diagnosis, whereas serious bacterial infection was the primary diagnosis in 44 cases of hospitalizations. Common opportunistic infection as primary diagnosis included cerebral toxoplasmosis, PCP (Pneumocystis carinii pneumonia), disseminated herpes infection, and cryptococcal meningitis. A non-HIV/AIDS-related condition was the primary final diagnosis in 30 admissions (18.7%). Median duration of the hospital stay was 9 days (range, 2-39 days). The outcome of these admissions was death in 30 (18.7%) cases, whereas the patient was discharged in the remaining 130 (81.3%) cases. Among the 96 male admissions, there were 19 (19.8%) deaths and 77 discharges, whereas among the 64 female admissions, there were 11 (17.2%) deaths and 53 discharges.
Death outcome was more common in persons with a history of poor adherence to HAART (22.1%) and those with a CD4 count of < 200 at the time of admission compared to persons with good adherence (13.1%) and those who had a CD4 count of ≥ 200, and these differences were statistically significant (P = .04 and .04, respectively). Although the persons with prior HIV diagnosis (21.2%) and those not on HAART (21.1%) also had higher mortality as compared to those who were diagnosed to be HIV infected during the current admission (17.1%) and those who were on HAART (19.6%), these differences were statistically not significant. Of the 130 discharges among the HIV-infected persons during the study period, a follow-up visit to the LRU within 6 weeks of discharge was recorded in 95 (73.1%) cases.
Discussion
Barbados is one of the smaller countries in the English-speaking Caribbean, with an estimated 2001 There is a provision for voluntary counseling and testing for HIV and an excellent facility for the follow-up care and treatment of all HIV-infected individuals in this country including provision for regular CD4 counts and viral load estimation to follow the course of this illness. HAART has been available for all eligible HIV-infected persons since 2001. All these facilities are provided through a centralized HIV follow-up clinic at the LRU, free of cost. We found that HIV-related hospitalizations in the only public hospital in Barbados constituted a significant proportion of all medical admissions in adults. Multiple hospitalizations were clustered in only an eighth of the HIV-infected persons. The majority of our admitted patients were heterosexual males in the age group 31 to 50 years, which is consistent with the sociodemographic profile of the newly diagnosed HIV-infected adults in this country. 16 Nearly half of all the HIV-related admissions were in persons not known to be HIV infected prior to this admission. Also, the majority of those admitted and who had HIV infection as one of the diagnoses had a CD4 count value < 200 and a viral load value of > 100,000 copies/mL. These data are consistent with the fact that late diagnosis of HIV infection continues to be a major problem in the HAART era and that this may offset the benefits of HAART in reducing the morbidity and mortality in this population. An earlier study from this population when HAART was being introduced in this country had also reported late diagnosis as a significant problem. 16 Late diagnosis of HIV infection is common despite the universal availability of voluntary testing facilities for HIV and antiretroviral therapy to all Barbadian public free of cost at the point of delivery. Findings from studies such as this one highlight the occurrence of late diagnosis of HIV in this country and should be used by health educators and counselors to encourage the general public to volunteer frequently for periodic testing for HIV. Indirectly and perhaps more important, these findings highlight the prevalence of a high degree of stigma and discrimination in society. 17 The issue of stigma and discrimination of HIV-infected persons is further compounded by the mode of delivery of health care and treatment for these people in this country. The centralized HIV/AIDS center, which was meant to be the "one stop shop" for all the health care needs of HIV-infected persons in this country, may prove to be a double-edged sword, whereby people may not want to be seen in a place popularly associated with HIV care, in a small society such as this where practically everybody knows everybody else.
Profile of Hospitalized HIV-Infected Persons
Consistent with the findings of a high proportion of the hospitalization occurring in newly diagnosed HIV-infected individuals who were not on any HAART and who had a low CD4 count, opportunistic infection remains the single most frequent cause of HIV-related hospitalization in this country in the era of HAART. Low CD4 counts, AIDS, and no current use of HAART were strongly correlated with hospitalizations, especially those due to opportunistic infections. 4, 7 What we also found is that prior diagnosis of HIV infection was also significantly more likely associated with severe immunosuppression (CD4 counts < 200) at the time of hospitalization and that more than half of those on HAART at the time of hospitalization had severe immunosuppression as well. Poor adherence and emergence of resistance to the HAART regimen may be the possible reasons for the immunologic failure in these patients on HAART. Nearly half of the patients on HAART were described to have poor adherence to the HAART regimen. Of those who had poor adherence, more than four fifths were on their third HAART regimen and all except one were on their second HAART regimen. After failing the first regimen, which consisted of a combination of combivir and nevirapine, nevirapine was empirically replaced by a protease inhibitor. No resistance testing was done in any of these patients. There are well-controlled prospective studies showing that HIV-related admissions from opportunistic infections occurred significantly more often in patients ignorant of their HIV status, those who did not have follow-up, and those who were noncompliant with their HAART. 18 However, slow immune recovery could account for immunosuppression in many patients. 19 There are some limitations to this retrospective observational study. Missing data were common, despite efforts to complete the data set. In particular, one third of patients were lacking viral load and CD4 count data, and complete treatment data for the entire cohort are lacking. Fortunately, the populationbased nature of this study cohort is a valuable asset and provides some compensation for this shortcoming. Losses to follow-up were common, with about one quarter of the cohort lost to follow-up by the end of the study period. These losses explain much of the missing data, and their numbers are comparable to other cohorts in public hospitals. This defines the need for better outreach programs and better strategies to retain patients once they are enrolled. The magnitude of loss of follow-up and delayed presentation for follow-up after diagnosis of HIV is discouraging, for it has occurred despite extensive efforts to create a one-stop-shopping model that is convenient for patients with disrupted lives.
In conclusion, we found that HIV-related hospitalizations were frequent in the HAART era. A significant proportion of patients admitted with HIV were newly diagnosed HIV-infected persons and were more likely to be severely immunosuppressed and to have a longer hospital stay with increased risk for mortality. Overall, hospitalization of HIV-infected persons still carries a significant risk of mortality. The clustering of hospitalizations in a small number of patients may enable the development of support programs targeted toward these "hospitalizationprone" patients to reduce recidivism.
